These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34098348)
1. Modified amino-dextrans as carriers of Gd-chelates for retrograde transport and visualization of peripheral nerves by magnetic resonance imaging (MRI). Pashkunova-Martic I; Manzano-Szalai K; Friske J; Aszmann O; Theiner S; Klose MHM; Baurecht D; Trattnig S; Keppler BK; Helbich TH J Inorg Biochem; 2021 Sep; 222():111495. PubMed ID: 34098348 [TBL] [Abstract][Full Text] [Related]
2. MR Imaging of Peripheral Nerves Using Targeted Application of Contrast Agents: An Experimental Proof-of-Concept Study. Tereshenko V; Pashkunova-Martic I; Manzano-Szalai K; Friske J; Bergmeister KD; Festin C; Aman M; Hruby LA; Klepetko J; Theiner S; Klose MHM; Keppler B; Helbich TH; Aszmann OC Front Med (Lausanne); 2020; 7():613138. PubMed ID: 33363189 [No Abstract] [Full Text] [Related]
3. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging. Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394 [TBL] [Abstract][Full Text] [Related]
4. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates? Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754 [TBL] [Abstract][Full Text] [Related]
5. Decoration of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) with N-oxides increases the T Kerpa S; Schulze VR; Holzapfel M; Cvancar L; Fischer M; Maison W ChemistryOpen; 2024 Jul; 13(7):e202300298. PubMed ID: 38224205 [TBL] [Abstract][Full Text] [Related]
6. Development of intravascular contrast agents for MRI using gadolinium chelates. Kittigowittana K; Yang CT; Cheah WC; Chuang KH; Tuang CY; Chang YT; Golay X; Bates RW ChemMedChem; 2011 May; 6(5):781-7. PubMed ID: 21433294 [TBL] [Abstract][Full Text] [Related]
7. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging. Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764 [TBL] [Abstract][Full Text] [Related]
8. Chelating DTPA amphiphiles: ion-tunable self-assembly structures and gadolinium complexes. Moghaddam MJ; de Campo L; Kirby N; Drummond CJ Phys Chem Chem Phys; 2012 Oct; 14(37):12854-62. PubMed ID: 22890045 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent. Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209 [TBL] [Abstract][Full Text] [Related]
11. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer. Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087 [TBL] [Abstract][Full Text] [Related]
12. A novel paramagnetic substrate for detecting myeloperoxidase activity in vivo. Shazeeb MS; Xie Y; Gupta S; Bogdanov AA Mol Imaging; 2012; 11(5):433-43. PubMed ID: 22954188 [TBL] [Abstract][Full Text] [Related]
13. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170 [TBL] [Abstract][Full Text] [Related]
14. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging. Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371 [TBL] [Abstract][Full Text] [Related]
15. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin. Battistini E; Gianolio E; Gref R; Couvreur P; Fuzerova S; Othman M; Aime S; Badet B; Durand P Chemistry; 2008; 14(15):4551-61. PubMed ID: 18386282 [TBL] [Abstract][Full Text] [Related]
16. Strategies for the covalent conjugation of a bifunctional chelating agent to albumin: synthesis and characterization of potential MRI contrast agents. Kundu A; Peterlik H; Krssak M; Bytzek AK; Pashkunova-Martic I; Arion VB; Helbich TH; Keppler BK J Inorg Biochem; 2011 Feb; 105(2):250-5. PubMed ID: 21194625 [TBL] [Abstract][Full Text] [Related]
17. Gd-complexes of macrocyclic DTPA conjugates of 1,1'-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs). Kim HK; Park JA; Kim KM; Nasiruzzaman SM; Kang DS; Lee J; Chang Y; Kim TJ Chem Commun (Camb); 2010 Nov; 46(44):8442-4. PubMed ID: 20886175 [TBL] [Abstract][Full Text] [Related]
18. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent. Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273 [TBL] [Abstract][Full Text] [Related]